Expanded Access Study for Renal Transplant Patients With Envarsus XR ™

Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological AE and Improve QOL

NCT03263052 ·Status: COMPLETED

Veloxis de Novo Kidney Transplant ECSWD

NCT03828682 ·Status: UNKNOWN ·Phase: PHASE4

Envarsus XR® in Adolescent Renal Transplant Recipients

NCT03266393 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes

NCT04711291 ·Status: WITHDRAWN ·Phase: NA

Envarsus in Delayed Graft Function (E-DGF)

NCT03864926 ·Status: COMPLETED ·Phase: PHASE4

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

NCT04469842 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients

NCT02432833 ·Status: COMPLETED ·Phase: PHASE4

Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants

NCT03841097 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

NCT03380936 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation

NCT03689075 ·Status: TERMINATED ·Phase: PHASE4

Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study

NCT02970630 ·Status: COMPLETED ·Phase: PHASE2

Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection

NCT03762473 ·Status: COMPLETED ·Phase: PHASE2

Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients

NCT06751992 ·Status: RECRUITING ·Phase: PHASE4

Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.

NCT03410654 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Envarsus XR in Lung Transplant

NCT04420195 ·Status: COMPLETED ·Phase: PHASE2

Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients

NCT02954198 ·Status: COMPLETED ·Phase: NA

Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant

NCT03386305 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients

NCT03438773 ·Status: UNKNOWN ·Phase: PHASE1

Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients

NCT03713645 ·Status: COMPLETED ·Phase: PHASE4

Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

NCT04773392 ·Status: TERMINATED ·Phase: PHASE4

Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen

NCT03373227 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

NCT00170833 ·Status: COMPLETED ·Phase: PHASE3

Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients

NCT03437577 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Envarsus XR in African American Renal Transplant Recipients

NCT02956005 ·Status: TERMINATED ·Phase: NA

Envarsus XL Immunosuppression Following Liver Transplantation

NCT03828058 ·Status: COMPLETED ·Phase: PHASE2